Drug of concern definition

Drug of concern means any drug that demonstrates a potential for abuse and is designated as a drug of concern in rules and regulations promulgated by the board.
Drug of concern means any drug or substance, including any controlled substance or other drug or
Drug of concern means any drug or substance, including any controlled substance or other drug or substance, where there has been or there is the potential for abuse and that has been identified by the Board of Pharmacy pursuant to § 54.1-3456.1.

Examples of Drug of concern in a sentence

  • Drug of concern" means any drug that demonstrates a potential for abuse and is designated as a drug of concern in rules and regulations promulgated by the board.


More Definitions of Drug of concern

Drug of concern means any prescription or over-the-counter medication that demonstrates a potential for abuse, particularly those identified by Boards of Pharmacy, law enforcement, and addiction treatment professionals.
Drug of concern. [OPTION 1] means a non-scheduled drug or a non-prescribed drug or substance listed in Schedules I, II, III, IV or V as determined by the [insert appropriate state agency] to be in need of monitoring because it has a potential for abuse or diversion or is required to be reported by the [insert appropriate state agency] for public health purposes.
Drug of concern. [OPTION 2] means a non-prescribed drug as determined by the [insert appropriate state agency] to be in need of monitoring because it has a potential for abuse or diversion or is required to be reported by the [insert appropriate state agency] for public health purposes.
Drug of concern means a drug other than a controlled substance that is identified by the [insert appropriate agency or entity] as demonstrating a potential for abuse and is designated as a drug of concern in rules and regulations.
Drug of concern means a drug, other than a controlled substance, as defined by rule which demonstrates a potential for abuse or diversion;
Drug of concern means a non-controlled dangerous drug that the Board has by rule determined to require dispenser PMP reporting of in the same manner as controlled substance prescription dispensing, when required reporting is expected to protect patients due to interaction of the drug of concern with controlled substances or other compelling issue. Gabapentin is a drug of concern.
Drug of concern means a non-controlled dangerous drug that the Board has by rule determined to require dispenser PMP reporting of in the same manner as controlled substance prescription dispensing, when required reporting is expected to protect patients due to interaction of the drug of concern with controlled substances or other compelling issue. Gabapentin is a drug of concern.[F.] G. “Patient” means the ultimate user of a drug for whom a prescription is issued and for whom a drug is dispensed.[G.] H. “Person” means an individual, corporation, business trust, estate, trust, partnership, limited liability company, association, joint venture or any legal or commercial entity.[H.] I. “PMP director” means the individual authorized by the board to administer the prescription monitoring program (PMP).[I.] J. “PMP report” means a compilation of data generated from the PMP concerning a patient, a dispenser, a practitioner, or a [schedules] schedule II - V controlled substance or drug(s) of concern.[J.] K. “Practitioner” means a person maintaining licensure pursuant to state law that allows him or her to prescribe controlled substance medications in accordance with that licensure.[K.] L. “Prescription monitoring program” (PMP) means a program as described in 16.19.29.6 NMAC which includes a centralized system to collect, monitor, and analyze electronically, for schedules II - V controlled substances and drug(s) of concern, prescribing and dispensing data submitted by dispensers of which the data is to be used to support efforts in education, research, enforcement and abuse prevention.[L.] M. “Schedule II - V controlled substance” means a substance listed in schedules II, III, IV, and V as set forth in the Controlled Substance Act, Sections 30-31-5 through 30-31-10 NMSA 1978 or the federal Controlled Substances Regulation (21 U.S.C. 812).[M ] N. “State” means the state of New Mexico.[16.19.29.7 NMAC - N, 07/15/2004; A, 06/11/2011; A, 08/31/2012; A, 10/24/2014; A, 03/22/2015; A, 11/27/2016; A, 09/25/2018; A, 02/28/2023]